scRNA-seq of PC9 EGFR-mutant NSCLC xenografts treated with osimertinib and/or trastuzumab deruxtecan

View at publisher Summarise with VIRAT
Authors: Ricardo J. Miragaia, Fernando J. Calero‐Nieto, Matthew J. Martin
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Fields of Study & Subjects

Lung Cancer Treatments and Mutations HER2/EGFR in Cancer Research Cancer Genomics and Diagnostics

Publication details

Publication date
30 March 2026
Language
EN
Document type
Dataset